background
rapid
detect
respiratori
virus
import
manag
infect
control
hospit
patient
multiplex
nucleic
acid
test
nat
begun
replac
convent
method
gold
standard
respiratori
viru
detect
object
compar
perform
two
larg
multiplex
nat
resplex
ii
rpii
respiratori
viru
surveil
kit
electrospray
ioniz
mass
spectrometri
rvsm
use
nasopharyng
aspir
npa
hospit
children
test
previous
convent
method
studi
design
store
residu
npa
n
test
concomitantli
rpii
rvsm
altern
nat
use
adjud
discord
result
result
virus
detect
multiplex
nat
rpii
rvsm
convent
assay
diagnost
gain
primarili
fastidi
virus
coronavirus
enterovirus
ev
human
rhinovirus
hrv
total
posit
neg
agreement
multiplex
nat
virus
detect
quit
high
posit
agreement
neg
agreement
individu
virus
detect
fairli
equival
accuraci
multiplex
nat
except
adenovirus
rpii
sensit
human
metapneumoviru
rvsm
sensit
rpii
advantag
detect
ev
hrv
howev
demonstr
consider
evhrv
crossreact
hrvposit
specimen
realtim
pcr
posit
ev
rpii
specimen
posit
hrv
rtpcr
dual
posit
evhrv
rpii
rpii
also
reduc
sensit
hrv
detect
specimen
hrv
detect
rtpcr
rpii
conclus
multiplex
nat
promis
notabl
limit
time
respiratori
viru
detect
hospit
import
patient
manag
infect
control
rapid
highli
sensit
nucleic
acid
test
nat
replac
convent
method
new
gold
standard
respiratori
viru
nat
vari
singleplex
multiplex
pcr
either
convent
realtim
format
multiplex
respiratori
nat
often
prefer
sinc
elimin
need
separ
nat
identifi
respiratori
virus
often
caus
overlap
clinic
present
resplex
ii
rpii
respiratori
viru
surveil
kit
electrospray
ioniz
mass
spectrometri
rvsm
two
larg
multiplex
nat
differ
amplificationdetect
design
rpii
contain
low
concentr
primer
pair
complementari
viral
target
heterolog
sequenc
second
high
concentr
primer
pair
contain
sequenc
complementari
heterolog
sequenc
design
favor
specif
target
amplif
earli
pcr
amplicon
amplif
later
cycl
improv
amplif
effici
reduc
background
respiratori
syncyti
viru
rsv
b
influenza
inf
b
parainfluenza
human
metapneumoviru
hmpv
coxsackievirusesechovirus
ev
herein
human
rhinoviru
hrv
adenoviru
b
e
adv
coronavirus
refer
collect
cov
bocaviru
detect
rvsm
assay
util
convent
pcr
electrospray
ioniz
mass
spectrometri
esim
detect
identifi
respiratori
virus
esim
use
convert
amplicon
duplex
singl
strand
determin
nucleotid
composit
measur
singl
strand
mass
observ
mass
compar
librari
expect
mass
identifi
amplifi
product
pcr
reaction
contain
exogen
intern
control
also
use
estim
target
analyt
concentr
rvsm
detect
similar
virus
rpii
except
design
detect
broader
array
adv
genotyp
af
detect
ev
hrv
purpos
studi
compar
abil
rpii
rvsm
detect
virus
nasopharyng
aspir
npa
clinic
wellcharacter
hospit
pediatr
patient
previous
test
convent
method
npa
collect
infant
toddler
n
upon
admiss
hospit
decemb
march
submit
convent
virolog
test
retrospect
cohort
select
test
well
character
clinic
residu
sampl
store
c
nucleic
acid
test
nat
perform
simultan
cell
pellet
process
npa
spot
onto
slide
stain
antibodi
inf
b
rsv
piv
adv
hmpv
ultra
screen
id
reagent
hmpv
reagent
diagnost
hybrid
inc
dhi
athen
oh
supernat
cultur
shell
vial
rmix
dhi
tube
cultur
rmix
coverslip
stain
h
ultra
screen
reagent
specif
id
reagent
appropri
tube
cultur
screen
cytopath
effect
week
confirmatori
stain
perform
appropri
total
nucleic
acid
extract
npa
use
qiasymphoni
sp
autom
instrument
qiasymphoni
virusbacteria
mini
test
kit
reagent
complex
protocol
qiagen
germantown
md
input
elut
volum
l
l
process
l
amplif
detect
reaction
perform
accord
manufactur
research
use
protocol
process
control
ad
qiasymphoni
extract
includ
intern
control
reagent
detect
human
genom
dna
proprietari
target
ascertain
sampl
qualiti
signal
detectionraw
data
analysi
signal
detect
luminex
system
use
qiaplex
mdd
softwar
inhous
determin
cutoff
valu
could
appli
distinguish
posit
result
requir
sinc
softwar
lack
interpret
criterion
four
differ
cutoff
valu
studi
includ
background
bkgd
mean
fluoresc
intens
mfi
valu
background
calcul
neg
control
mfi
assay
multipli
three
use
cutoff
defin
posit
sampl
within
run
decid
cutoff
valu
appropri
result
obtain
cutoff
compar
rvsm
discrep
analysi
altern
pcr
assay
convent
test
result
two
cutoff
mfi
bkgd
mfi
show
best
correl
aggreg
data
test
method
bkgd
cutoff
select
demonstr
excel
overal
agreement
method
allow
interrun
data
normal
account
runtorun
variabl
background
fluoresc
purpos
studi
rsv
b
differenti
bocaviru
includ
analysi
sinc
import
respiratori
pathogen
firmli
establish
rvsm
ibi
bioscienc
inc
part
abbott
molecular
de
plain
il
target
amplif
perform
describ
previous
use
mastercycl
ep
gradient
eppendorf
hamburg
de
amplif
product
desalt
analyz
use
univers
biosensor
timeofflight
mass
spectromet
two
differ
realtim
rtpcr
assay
ev
hrv
use
compar
rpii
sinc
virus
detect
rvsm
assay
perform
describ
follow
modif
qiasymphoni
use
extract
realtim
pcr
perform
quantitect
viru
kit
qiagen
real
time
pcr
system
c
min
c
min
cycl
c
c
min
discord
result
adjud
altern
nat
tabl
highli
sensit
singleplex
assay
copiesreact
demonstr
publish
inhous
data
select
use
multiplex
nat
xtag
rvp
luminex
austin
tx
use
singleplex
assay
met
criteria
readili
avail
tabl
data
store
excel
microsoft
redmond
wa
analyz
use
stata
version
statacorp
colleg
station
tx
posit
neg
agreement
viru
total
posit
neg
calcul
use
rpii
test
assay
rvsm
compar
assay
sinc
agreement
analysi
highlight
defici
viru
detect
rpii
minim
detect
defici
rvsm
assess
sensit
specif
likewis
piv
analyz
singl
group
piv
sinc
combin
total
number
piv
detect
four
cov
analyz
group
sinc
current
clinic
util
distinguish
virus
individu
ev
hrv
discord
result
adjud
third
assay
therefor
agreement
determin
confid
interv
calcul
use
webbas
calcul
posit
signal
statist
data
provid
supplement
data
tabl
calcul
use
excel
number
virus
detect
rpii
rvsm
similar
vs
tabl
greater
number
detect
convent
method
n
virus
detect
sampl
rpii
rvsm
convent
method
respect
data
shown
rsv
commonli
identifi
method
tabl
second
third
commonli
detect
virus
vari
multiplex
inf
hmpv
cov
next
preval
virus
found
rpii
inf
preval
overal
identifi
virus
hmpv
cov
preval
overal
identifi
virus
adv
inf
found
rvsm
adv
preval
overal
identifi
virus
inf
preval
overal
identifi
virus
cov
detect
convent
method
fairli
common
preval
overal
identifi
virus
similarli
detect
multiplex
nat
rel
diagnost
perform
two
multiplex
nat
individu
sampl
high
fairli
equival
virus
determin
agreement
analys
assay
sensitivityspecif
tabl
lowest
posit
agreement
observ
adv
lowest
neg
agreement
observ
hmpv
resolut
discord
result
either
altern
nat
convent
result
delin
dispar
detect
two
virus
multiplex
nat
sensit
adv
rpii
hmpv
rvsm
asid
sampl
neg
virus
rpii
rtpcr
littl
agreement
evhrv
result
individu
sampl
tabl
sampl
dual
posit
hrv
plu
ev
rpii
rtpcr
one
sampl
posit
ev
rpii
rtpcr
sampl
posit
hrv
rpii
rtpcr
rpii
detect
ev
greater
number
sampl
rtpcr
vs
data
suggest
crossreact
rpii
ev
hrv
detect
reagent
rather
enhanc
sensit
ev
detect
sinc
ev
posit
sampl
dual
posit
ev
contain
hrv
rtpcr
furthermor
larg
proport
rpii
ev
onlyrtpcr
neg
sampl
would
expect
ev
effect
detect
rpii
howev
two
sampl
identifi
contrast
ev
detect
rpii
detect
hrv
fewer
sampl
rtpcr
vs
notabl
sampl
found
contain
hrv
rna
rtpcr
neg
rpii
tabl
mean
ct
valu
hrvposit
sampl
highest
categori
found
contain
hrv
rtpcr
analysi
supplement
data
tabl
suggest
sampl
contain
low
target
rna
level
fourteen
sampl
posit
hrv
ev
rtpcr
posit
ev
rpii
qualit
concord
analysi
sampl
would
appear
fals
posit
rtpcr
result
howev
analysi
signal
strength
suggest
opposit
mean
median
hrv
ct
valu
lowest
categori
sampl
found
contain
hrv
rtpcr
mean
median
see
supplement
data
tabl
data
suggest
erron
ev
detect
rpii
rtpcr
sampl
contain
high
hrv
concentr
simpl
agreement
tabl
specif
viru
combin
virus
differenti
tabl
bottom
panel
evhrv
specifi
construct
given
high
degre
sequenc
concord
ev
hrv
absenc
definit
sequenc
data
studi
sampl
posit
agreement
analysi
fairli
high
even
analysi
howev
singleplex
realtim
rt
pcr
sensit
sinc
detect
evhrv
sampl
neg
rpii
larg
due
number
sampl
posit
rtpcr
hrv
neg
rpii
coinfect
virus
evhrv
found
rel
sampl
rpii
rvsm
confirm
coinfect
contain
cov
specif
supplement
data
tabl
coinfect
enterovirus
ev
hrv
virus
found
sampl
rpii
supplement
data
tabl
nat
power
tool
diagnosi
manag
respiratori
viru
infect
due
enhanc
sensit
rapid
time
result
deep
multiplex
also
import
advantag
allow
identif
usual
pathogen
rsv
inf
adv
also
unsuspect
typic
lower
virul
virus
piv
hrv
cov
caus
lower
respiratori
tract
diseas
therefor
significantli
pathogen
highli
suscept
host
perform
comparison
studi
sampl
hospit
children
highli
multiplex
rpii
rvsm
assay
detect
virus
fairli
equival
accuraci
except
hmpv
adv
effect
detect
rpii
rvsm
respect
low
adv
detect
rate
rpii
compar
differ
extens
multiplex
respiratori
viru
nat
seeplex
previous
report
independ
publish
confirm
low
hmpv
detect
rate
rvsm
compar
altern
nat
lack
given
adv
hmpv
highli
preval
caus
seriou
diseas
potenti
diagnost
shortcom
signific
repres
opportun
perform
enhanc
subsequ
gener
assay
unfortun
preval
piv
low
make
definit
conclus
regard
rel
efficaci
rpii
rvsm
also
note
studi
design
preclud
conclus
regard
true
vs
rel
accuraci
sensit
therefor
accuraci
detect
virus
compar
quit
high
test
gold
standard
nat
analyt
might
reveal
addit
detect
defici
common
rpii
rvsm
rpii
manufactur
suppli
cutoff
mfi
valu
allow
differenti
posit
neg
result
method
comparison
studi
design
allow
analysi
multipl
cutoff
defin
variabl
cutoff
base
intrarun
background
signal
function
well
offer
theoret
advantag
correct
interrun
background
variabl
addit
studi
larger
cohort
requir
conclus
establish
superior
maxim
clinic
util
respiratori
viru
nat
detect
broadest
rang
pathogen
target
rpii
provid
better
diagnost
potenti
current
version
rvsm
sinc
detect
evhrv
fact
studi
preval
evhrv
highest
virus
includ
rpii
rtpcr
posit
howev
rpii
limit
regard
evhrv
detect
first
data
suggest
crossreact
rpii
ev
hrv
detect
reagent
suggest
previou
studi
note
discord
evhrv
result
limit
number
sampl
high
proport
evhrv
dual
posit
data
impli
crossreact
extens
previous
appreci
given
number
discord
rpii
evrtpcr
hrv
rpii
dualrtpcr
hrv
specimen
one
curiou
result
number
specimen
found
dual
posit
rtpcr
posit
ev
rpii
qualit
basi
result
would
appear
suggest
fals
posit
hrv
rtpcr
result
howev
signal
strength
data
point
differ
conclus
low
mean
median
hrv
rtpcr
ct
valu
suggest
sampl
like
contain
hrv
impli
issu
ev
detect
specif
rpii
rtpcr
sensit
hrv
detect
rpii
publish
data
unpublish
observ
ev
rtpcr
reagent
suggest
propens
crossreact
intern
studi
ev
hrv
rtpcr
reagent
demonstr
hrv
npa
also
amplifi
ev
rtpcr
sequenc
data
obtain
sampl
demonstr
hrv
hrv
rtpcr
specif
much
greater
ev
rtpcr
latter
develop
compar
analysi
extens
sequenc
librari
compar
ev
rtpcr
shown
crossamplifi
ev
artifici
sampl
spike
high
concentr
synthet
transcript
improv
evhrv
concord
rpii
rtpcr
observ
posit
result
group
evhrv
unspecifi
may
accur
approach
report
rpii
result
howev
even
group
report
appar
rpii
miss
approxim
one
third
infect
detect
singleplex
rtpcr
similar
defect
evhrv
detect
compar
altern
nat
report
subsequ
version
assay
would
benefit
improv
hrv
sensit
given
report
hrv
caus
clinic
signific
diseas
coinfect
virus
evhrv
observ
strikingli
confirm
nonevhrv
coinfect
includ
copathogen
biolog
signific
unclear
data
avail
literatur
among
evhrv
coinfect
domin
nonenterovir
pathogen
observ
identifi
virus
reflect
spectrum
commonli
observ
young
children
greatest
diagnost
gain
extend
panel
nat
larg
virus
challeng
detect
convent
method
virus
rsv
flua
readili
detect
dfa
cultur
equival
detect
nat
convent
method
piv
preval
low
make
conclus
statement
regard
rel
efficaci
convent
vs
nat
panel
data
suggest
improv
detect
nat
deepli
multiplex
respiratori
viru
nat
replac
cell
cultur
use
immunocompromis
popul
center
wake
influenza
pandem
due
perceiv
benefit
rapid
highli
sensit
result
would
provid
patient
manag
sever
year
experi
test
becom
appar
characterist
optim
respiratori
viru
nat
includ
abil
detect
broadest
rang
respiratori
viru
pathogen
highli
accur
detect
viru
low
labor
requir
result
avail
within
singl
shift
low
contamin
rate
increas
avail
deepli
multiplex
commerci
respiratori
viru
nat
offer
opportun
compar
perform
characterist
studi
rpii
current
version
rvsm
suggest
strength
demonstr
limit
regard
fit
profil
perfect
assay
work
fund
rbabi
foundat
reagent
support
kindli
provid
qiagen
ibi
biosciencesabbott
molecular
c
gaydo
receiv
research
fund
abbottibi
valsamaki
receiv
research
fund
abbottibi
qiagen
serv
scientif
advisori
board
diagnost
hybrid
inc
studi
approv
john
hopkin
school
medicin
institut
review
board
studi
na
